Ahmedabad, India

Prashant Rameshchandra Bhatt

This inventor holds 1 USPTO granted patent. Top assignee: Cadila Healthcare Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prashant Rameshchandra Bhatt. Retrieved from https://idiyas.com/inventor/prashant-rameshchandra-bhatt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Prashant Rameshchandra Bhatt: Advancing Pharmaceutical Sciences

Introduction

Prashant Rameshchandra Bhatt is a notable inventor based in Ahmedabad-Gujarat, India. He is recognized for his contributions to the pharmaceutical industry, particularly in the development of formulations that enhance therapeutic efficacy.

Latest Patents

Prashant holds a patent for the "Crystalline form of rifaximin and process for its preparation." This invention involves a novel crystalline form of rifaximin, which is significant in improving the efficacy of the medication. Additionally, the patent describes a pharmaceutical composition comprising crystalline rifaximin, showcasing his innovative approach to drug formulation.

Career Highlights

Prashant is a distinguished employee at Cadila Healthcare Limited, a prominent player in the pharmaceutical sector. His work primarily focuses on enhancing drug formulations and improving patient outcomes through innovative solutions.

Collaborations

Throughout his career, Prashant has collaborated with talented professionals such as Kumar Kamlesh Singh and Nikhil Amar Singh. Together, they have worked towards advancing pharmaceutical innovations that benefit the healthcare industry.

Conclusion

Prashant Rameshchandra Bhatt's research and developments in pharmaceutical sciences exemplify the spirit of innovation. His patent for a novel crystalline form of rifaximin demonstrates his commitment to improving healthcare solutions, solidifying his position as an influential inventor in the pharmaceutical landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…